IPO Date: Mar 24 to Mar 27 2026
Listing Date: Apr 2 2026
1. Capacity expansion and upgradation of manufacturing facilities;
2. Establishment of a new R&D Centre;
3. Repayment / prepayment of certain outstanding borrowings;
4. Working capital requirements;
5. Investment in wholly owned subsidiary, Sai Parenterals Pte Limited (Singapore), in relation to the proposed acquisition of Noumed Pharmaceuticals Pty Limited (Australia); and
6. General corporate purposes
Plot No.39, 5th Floor, Lavanya Arcade Jayabheri Enclave, Gachibowli, K. V Seri Lingampally
Rangareddy
Telangana
500032
7997991306
cs@saiparenterals.com / info@saiparenterals.com
www.saiparenterals.com
Bigshare Services Pvt Ltd
Pursuant to Regulation 30 and other applicable provisions of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’), Sai Parenterals has informed that it enclosed copies of the Newspaper Advertisement published in PAS-1 by the Company with details regarding proposed change and variation in the objects of utilization of the Initial Public Offering (‘IPO’) proceeds, in compliance with requirement under the Companies Act, 2013. The advertisements were published today (ie. on 20th August, 2026) in the newspapers: Financial Express (English) and Mana Telangana (Telugu). The newspaper publications are also made available on its website at the following link https://www.saiparenterals.com/.
The above information is a part of company’s filings submitted to BSE.
In reference to the disclosure filed by the Company under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘LODR Regulations’) dated July 13th 2023, July 14th 2023 and January 02, 2024 with respect to Show Cause Notice (SCN) dated 22 August, 2022 issued against the Company by The Commissioner of GST and Central Excise, Audit II Commissionerate, No. 692, 6th Floor, MHU Complex, Anasalai, Nandanam, Chennai- 600 035. In this regard, Jamna Auto Industries has informed that update on the matter is given at Annexure-A.
The above information is a part of company’s filings submitted to BSE.
Arfin India has informed that meeting of the Board of Directors of the company was held today, Friday, September 18, 2026 at Registered Office situated at Plot No.117, Ravi Industrial Estate, Behind Prestige Hotel, Billeshwarpura, Chhatral, Gandhinagar-382729, Gujarat, India. Pursuant to the provisions of Regulation 30 and 42 of SEBI (LODR) Regulation, 2015, following is the outcome of the Board meeting whereby the Board has: 1. The payment of Interim Dividend of Rs 0.12/- per equity share of face value of Rs. 1/- each for the financial year 2026-27 and have fixed Thursday, September 24, 2026 as the 'Record Date' for determining the shareholders who will be entitled to the said Dividend. The Interim Dividend will be paid to the entitled shareholders within 30 days from the date of declaration. The above information will also be available on the Company's website at www.arfin.co.in. The meeting of the Board of Directors of the Company commenced at 09.15 a.m. and concluded at 10.15 am.
The above information is a part of company’s filings submitted to BSE.
No Records Found
The issue size of Sai Parenteral's Ltd. IPO is ₹279.84 - 294.88 crore.
The Sai Parenteral's Ltd. IPO opens for subscription on 2026-03-24 and closes on 2026-03-27.
The price range of Sai Parenteral's Ltd. IPO is ₹372.00 to ₹392.00.
The lot size of Sai Parenteral's Ltd. IPO is 38 shares.
The registrar of Sai Parenteral's Ltd. IPO is Bigshare Services Pvt Ltd .
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.